FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004267218> ?p ?o ?g. }

• W2004267218 endingPage "373" @default.
• W2004267218 startingPage "365" @default.
• W2004267218 abstract "In Brief OBJECTIVE: Limited data exist to inform clinicians and patients as to the likelihood of long-term endometrial hyperplasia response to progestin therapy, especially for atypical hyperplasia. We evaluated women with complex and atypical endometrial hyperplasia, comparing those prescribed progestin with those not prescribed progestin. METHODS: This retrospective cohort study was conducted in 1985–2005 among women aged 18–88 years at an integrated health plan in Washington State. Women were ineligible if they achieved an outcome (endometrial carcinoma, hysterectomy, or both) within 8 weeks of hyperplasia diagnosis. Exposure was progestin use for at least 14 days by duration and recency. Outcomes included rate of 1) endometrial carcinoma, 2) hysterectomy, or 3) both. Analyses performed included Kaplan-Meier, incident rate ratios, and Cox proportional hazard ratios. RESULTS: One thousand four hundred forty-three eligible women were identified. One thousand two hundred one had complex (n=164 no progestin) and 242 had atypical (n=62 no progestin) hyperplasia. During follow-up, a median of 5.3 years (range 8 weeks to 20.8 years), 71 women were diagnosed with endometrial carcinoma (35 complex, 36 atypia) and 323 underwent hysterectomy (216 complex, 107 atypia). Among women with complex and atypical hyperplasia, rates of endometrial carcinoma among progestin users were 3.6 and 20.5 per 1,000 woman-years, respectively (compared with women who did not use progestin, 10.8 and 101.4). Among women with complex and atypical hyperplasia, rates of hysterectomy among progestin users were 23.3 and 61.4 per 1,000 woman-years, respectively (compared with women who did not use progestin, 55.1 and 297.3). CONCLUSION: Endometrial carcinoma risk is diminished approximately threefold to fivefold in women diagnosed with complex or atypical endometrial hyperplasia and dispensed progestin; hysterectomy risk is also decreased. LEVEL OF EVIDENCE: II Endometrial carcinoma risk is diminished threefold to fivefold in women diagnosed with complex or atypical endometrial hyperplasia and prescribed progestin; hysterectomy risk is also decreased." @default.
• W2004267218 created "2016-06-24" @default.
• W2004267218 creator A5006470796 @default.
• W2004267218 creator A5016958524 @default.
• W2004267218 creator A5030569800 @default.
• W2004267218 creator A5049708025 @default.
• W2004267218 creator A5055349575 @default.
• W2004267218 creator A5057623385 @default.
• W2004267218 creator A5084420374 @default.
• W2004267218 creator A5086632845 @default.
• W2004267218 creator A5090089564 @default.
• W2004267218 creator A5090374110 @default.
• W2004267218 creator A5090852072 @default.
• W2004267218 date "2010-08-01" @default.
• W2004267218 modified "2023-10-11" @default.
• W2004267218 title "Complex Hyperplasia With and Without Atypia" @default.
• W2004267218 cites W153466153 @default.
• W2004267218 cites W1643388074 @default.
• W2004267218 cites W1973733252 @default.
• W2004267218 cites W1984530482 @default.
• W2004267218 cites W1997098766 @default.
• W2004267218 cites W2004259949 @default.
• W2004267218 cites W2005081204 @default.
• W2004267218 cites W2016751245 @default.
• W2004267218 cites W2022987638 @default.
• W2004267218 cites W2024827041 @default.
• W2004267218 cites W2030442521 @default.
• W2004267218 cites W2033522005 @default.
• W2004267218 cites W2036293145 @default.
• W2004267218 cites W2042017445 @default.
• W2004267218 cites W2046352003 @default.
• W2004267218 cites W2047111383 @default.
• W2004267218 cites W2051078146 @default.
• W2004267218 cites W2064617101 @default.
• W2004267218 cites W2069197273 @default.
• W2004267218 cites W2075416644 @default.
• W2004267218 cites W2092399942 @default.
• W2004267218 cites W2097113048 @default.
• W2004267218 cites W2117582176 @default.
• W2004267218 cites W2133135985 @default.
• W2004267218 cites W2135109253 @default.
• W2004267218 cites W2146896519 @default.
• W2004267218 cites W2158134384 @default.
• W2004267218 cites W2172094497 @default.
• W2004267218 cites W4234114680 @default.
• W2004267218 cites W4236267546 @default.
• W2004267218 doi "https://doi.org/10.1097/aog.0b013e3181e93330" @default.
• W2004267218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2949551" @default.
• W2004267218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20664397" @default.
• W2004267218 hasPublicationYear "2010" @default.
• W2004267218 type Work @default.
• W2004267218 sameAs 2004267218 @default.
• W2004267218 citedByCount "68" @default.
• W2004267218 countsByYear W20042672182012 @default.
• W2004267218 countsByYear W20042672182013 @default.
• W2004267218 countsByYear W20042672182014 @default.
• W2004267218 countsByYear W20042672182015 @default.
• W2004267218 countsByYear W20042672182016 @default.
• W2004267218 countsByYear W20042672182017 @default.
• W2004267218 countsByYear W20042672182018 @default.
• W2004267218 countsByYear W20042672182019 @default.
• W2004267218 countsByYear W20042672182020 @default.
• W2004267218 countsByYear W20042672182021 @default.
• W2004267218 countsByYear W20042672182022 @default.
• W2004267218 countsByYear W20042672182023 @default.
• W2004267218 crossrefType "journal-article" @default.
• W2004267218 hasAuthorship W2004267218A5006470796 @default.
• W2004267218 hasAuthorship W2004267218A5016958524 @default.
• W2004267218 hasAuthorship W2004267218A5030569800 @default.
• W2004267218 hasAuthorship W2004267218A5049708025 @default.
• W2004267218 hasAuthorship W2004267218A5055349575 @default.
• W2004267218 hasAuthorship W2004267218A5057623385 @default.
• W2004267218 hasAuthorship W2004267218A5084420374 @default.
• W2004267218 hasAuthorship W2004267218A5086632845 @default.
• W2004267218 hasAuthorship W2004267218A5090089564 @default.
• W2004267218 hasAuthorship W2004267218A5090374110 @default.
• W2004267218 hasAuthorship W2004267218A5090852072 @default.
• W2004267218 hasBestOaLocation W20042672182 @default.
• W2004267218 hasConcept C121608353 @default.
• W2004267218 hasConcept C126322002 @default.
• W2004267218 hasConcept C131872663 @default.
• W2004267218 hasConcept C141071460 @default.
• W2004267218 hasConcept C142724271 @default.
• W2004267218 hasConcept C167135981 @default.
• W2004267218 hasConcept C207103383 @default.
• W2004267218 hasConcept C2775904963 @default.
• W2004267218 hasConcept C2776607906 @default.
• W2004267218 hasConcept C2777088508 @default.
• W2004267218 hasConcept C2777164284 @default.
• W2004267218 hasConcept C2777546739 @default.
• W2004267218 hasConcept C2777562237 @default.
• W2004267218 hasConcept C2777689261 @default.
• W2004267218 hasConcept C2779494336 @default.
• W2004267218 hasConcept C2779742232 @default.
• W2004267218 hasConcept C2781283455 @default.
• W2004267218 hasConcept C29456083 @default.
• W2004267218 hasConcept C44249647 @default.
• W2004267218 hasConcept C71924100 @default.

• next